Orli Friedman-Eldar1,2, Jonathan Burke3,4, Iago de Castro Silva5, Camille C Baumrucker4, Fernando Valle4,6, Anne-Sophie Lessard7, Wrood Kassira7, Dido Franceschi5, Susan B Kesmodel5, Eli Avisar5, Neha Goel5, Mecker G Möller5. 1. Breast Surgical Oncology Department, Jackson Memorial Hospital, Miami, FL, USA. eldaror@gmail.com. 2. Breast surgical Oncology Department, Kaplan Medical Center, Rehovot, Israel. eldaror@gmail.com. 3. Department of Surgery, New York University School of Medicine, NewYork, NY, USA. 4. University of Miami, Miller School of Medicine, Miami, FL, USA. 5. Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, USA. 6. University of El Salvador, San Salvador, El Salvador. 7. Division of Plastic Surgery, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.
Abstract
PURPOSE: Post-mastectomy breast reconstruction (PMBR) is an important component of breast cancer treatment, but disparities relative to insurance status persist despite legislation targeting the issue. We aimed to study this relationship in a large health system combining a safety-net hospital and a private academic center. METHODS: Data were collected on all patients who underwent mastectomy for breast cancer from 2011 to 2019 in a private academic center and an adjacent public safety-net hospital served by the same surgical teams. Multivariable logistic regression was used to assess the effect of insurance status on PMBR, controlling for covariates that included socioeconomic, demographic, and clinical factors. RESULTS: Of 1554 patients undergoing mastectomy for breast cancer, 753 (48.5%) underwent PMBR, of which 592 (79.9%) were privately insured, 50 (6.7%) Medicare, 68 (9.2%) Medicaid, and 31 (4.2%) uninsured. Multivariable logistic regression showed a significantly higher likelihood of not undergoing PMBR for uninsured (OR 6.0, 95% CI 3.7-9.8; p < 0.0001), Medicare (OR 1.9, (95% CI 1.2-3.0; p = 0.006), and Medicaid (OR 1.5, 95% CI 1.0-2.3; p = 0.04) patients compared with privately insured patients. Age, stage, race and ethnicity, and hospital type confounded this relationship. CONCLUSION: Patients without health insurance have dramatically reduced access to PMBR compared to those with private insurance. Expanding access to this important procedure is essential to achieve greater health equity for breast cancer patients.
PURPOSE: Post-mastectomy breast reconstruction (PMBR) is an important component of breast cancer treatment, but disparities relative to insurance status persist despite legislation targeting the issue. We aimed to study this relationship in a large health system combining a safety-net hospital and a private academic center. METHODS: Data were collected on all patients who underwent mastectomy for breast cancer from 2011 to 2019 in a private academic center and an adjacent public safety-net hospital served by the same surgical teams. Multivariable logistic regression was used to assess the effect of insurance status on PMBR, controlling for covariates that included socioeconomic, demographic, and clinical factors. RESULTS: Of 1554 patients undergoing mastectomy for breast cancer, 753 (48.5%) underwent PMBR, of which 592 (79.9%) were privately insured, 50 (6.7%) Medicare, 68 (9.2%) Medicaid, and 31 (4.2%) uninsured. Multivariable logistic regression showed a significantly higher likelihood of not undergoing PMBR for uninsured (OR 6.0, 95% CI 3.7-9.8; p < 0.0001), Medicare (OR 1.9, (95% CI 1.2-3.0; p = 0.006), and Medicaid (OR 1.5, 95% CI 1.0-2.3; p = 0.04) patients compared with privately insured patients. Age, stage, race and ethnicity, and hospital type confounded this relationship. CONCLUSION: Patients without health insurance have dramatically reduced access to PMBR compared to those with private insurance. Expanding access to this important procedure is essential to achieve greater health equity for breast cancer patients.
Authors: J Dauplat; F Kwiatkowski; P Rouanet; E Delay; K Clough; J L Verhaeghe; I Raoust; G Houvenaeghel; P Lemasurier; E Thivat; C Pomel Journal: Br J Surg Date: 2017-04-12 Impact factor: 6.939
Authors: Usama Mahmood; Alexandra L Hanlon; Matthew Koshy; Robert Buras; Saranya Chumsri; Katherine H Tkaczuk; Sally B Cheston; William F Regine; Steven J Feigenberg Journal: Ann Surg Oncol Date: 2012-11-08 Impact factor: 5.344
Authors: David J W Keith; Mary B Walker; Leslie G Walker; Steven D Heys; Tarun K Sarkar; Andrew W Hutcheon; Oleg Eremin Journal: Plast Reconstr Surg Date: 2003-03 Impact factor: 4.730
Authors: Ioanna Fanakidou; Sofia Zyga; Victoria Alikari; Maria Tsironi; John Stathoulis; Paraskevi Theofilou Journal: Qual Life Res Date: 2017-11-08 Impact factor: 4.147